Bazelet Group

Bazelet Group Overview

Bazelet Technologies is a cannabis scientific incubator focused on developing innovative enriched-cannabis products. Bazelet Group processes the cannabis grown by four of the eight legal farms in Israel, serving 9,000 patients per month, and is constructing a GMP facility with the capacity for 100,000 patients. Its products include cannabis buds in sealed, barcoded packages; flowers ground in a proprietary method; cannabis cigarettes; cannabis extracts; vaporizer tablets; sustained-release capsules; topicals; and suppositories. Bazelet's operations also include providing secure delivery to homes every month, educating newly licensed users, guiding and offering strain-selection advice to thousands of clients, and operating a call center. The company develops new technologies for vaporizers, veterinary applications, and new delivery methods. Bazelet Group operates as a subsidiary of Jordache Enterprises Inc, Canada, and consists of four cannabis pharmaceutical companies: Bazelet Pharma, Bazelet Nehushtan, Bazelet Technologies, and Bazelet Know-How.

Latest News

Jun 8, 2021 · www.globenewswire.com

growth-positive

Ayurcann Expansion Continues with New Joint Venture with Largest Medical Cannabis Company in Israel

Ayurcann Holdings Corp. has entered into a joint venture agreement with Bazelet Nehushtan Ltd. and/or Bazelet Development and Technologies Ltd. to manufacture proprietary products for the Canadian market. Bazelet is a licensed medical cannabis processor based in Israel and one of the largest medical cannabis companies in the country. The joint venture agreement allows Ayurcann to be the Canadian manufacturer of all Bazelet products. This partnership is expected to introduce unique products into the Canadian marketplace and provide opportunities for continuous product introductions. Ayurcann is focused on expanding its domestic operations and seeking new market possibilities and partnerships to grow in the cannabis industry.

PartnersExpand

Jan 11, 2021 · www.prnewswire.com

growth-positive

Bazelet launches first-of-the kind, proprietary, terpene-enriched medical cannabis oils specially designed for medical needs such as women health, pain treatment, improved sleep and special needs of the elderly population

Bazelet, the largest medical company in Israel, has launched multiple lines of terpene-enriched cannabis oils designed for various indications and personal needs. The company has developed a unique way of formulating medical cannabis oils by controlling their terpene content. Bazelets oils have a higher terpene content than common cannabis oils and are referred to as terpenes-enriched. The company has filed patent applications to protect its terpene-enriched formulations. Bazelet also offers patent-protected terpene blends to be added to extracts produced in other geographies. The technology has the potential for growth and positive impact on the company.

Customers

Funding

Team Members

4

Employees: 11-50

Web & Social Links

Locations

Ha-Histadrut St 2, Nesher, Israel

Photos & Videos

4 item(s)

Bazelet Group Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info